Profile
Yasuo Fujii is Director at Orchard Therapeutics Plc since 2024.
Mr. Fujii is Chief Strategy Officer at Kyowa Kirin Co., Ltd. since 2023.
Formerly, Mr. Fujii was Executive Vice President-Corporate Planning at Kyowa Kirin International Plc.
Mr. Fujii earned an MBA from the University of Illinois.
Yasuo Fujii active positions
| Companies | Position | Start |
|---|---|---|
| KYOWA KIRIN CO., LTD. | Corporate Officer/Principal | 01/04/1988 |
| ORCHARD THERAPEUTICS PLC | Director/Board Member | 24/01/2024 |
Former positions of Yasuo Fujii
| Companies | Position | End |
|---|---|---|
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases | Corporate Officer/Principal | - |
Training of Yasuo Fujii
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases | Health Technology |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals; develops biochemical reagents and other chemicals | Health Technology |
Orchard Therapeutics Plc
Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
- Stock Market
- Insiders
- Yasuo Fujii
















